However, the two approaches are not mutually exclusive
The Risk of Research Peptides Like DSIP Most people come across DSIP through: Peptide websites Research use only suppliers Forums and social media That creates real risks: No regulation or quality control Unknown purity and dosing No safety oversight No long-term human data Even though DSIP is not an opioid, using unregulated compounds during recovery can still: Disrupt progress Create new dependencies on routines or substances Mask underlying issues without treating them Why People in Recovery Are Drawn to It This part matters
Side Effects and Complications NAD+ Infusion Symptoms Nausea, abdominal discomfort or cramping, chest pressure or tightness, flushing, dizziness, headache, chills, shaking, vomiting, and fatigue have been reported with injectable NAD+ products or commercial infusions
The good news is that there are multiple evidence-based treatment options, and many patients improve with the right clinician-guided plan
Rhonda Patrick: I would love to